Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

Published:2021-03 Issue:1 Volume:8 Page:573-584
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Askanase Anca D.,Wan George J.,Panaccio Mary P.,Zhao Enxu,Zhu Julie,Bilyk Roman,Furie Richard A.

Funder

Mallinckrodt Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40744-021-00294-z.pdf

Reference30 articles.

1. Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13.

2. Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016;12(10):605–20.

3. Barber MRW, Clarke AE. Socioeconomic consequences of systemic lupus erythematosus. Curr Opin Rheumatol. 2017;29(5):480–5.

4. Mahieu M, Yount S, Ramsey-Goldman R. Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin N Am. 2016;42(2):253–63.

5. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predict patients’ health-related quality of life? Lupus. 2004;13(12):924–6.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severity Scores for Cutaneous Lupus Erythematosus;Journal of Investigative Dermatology;2024-09

2. Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence;Clinical Drug Investigation;2023-10

3. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence;ClinicoEconomics and Outcomes Research;2023-06

4. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus;Advances in Therapy;2022-10-20

5. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus;ADV THER;2022